{"id":"W4402535093","doi":"10.1016/s0140-6736(24)01808-7","title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"Meso Scale Diagnostics","keywords":"Pembrolizumab; Medicine; Placebo; Chemoradiotherapy; Cervical cancer; Internal medicine; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001650365,0.001409392,0.004729706,0.0002803451,0.0004865854,0.0004519208,0.001023066,0.0005699417,0.002185938],"category_scores_gemma":[0.001192283,0.0007293071,0.0009745205,0.001091486,0.0002996742,0.0003762949,0.0001192218,0.001264846,0.00009910162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001046608,"about_ca_system_score_gemma":0.001840189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005197448,"about_ca_topic_score_gemma":0.004660626,"domain_scores_codex":[0.992265,0.0006935011,0.001788879,0.0019277,0.001592412,0.001732526],"domain_scores_gemma":[0.9867086,0.009877459,0.000717191,0.001660207,0.0002978203,0.0007386991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9405124,0.001275836,0.00003530969,0.0002974826,0.004688005,0.0005025368,0.0007318337,0.0005228886,0.0004056607,0.00009337613,0.03416414,0.01677057],"study_design_scores_gemma":[0.9328958,0.009884923,0.00002363067,0.0007073974,0.003285514,0.0000450121,0.0001442048,0.002467295,0.001557047,0.0001975695,0.04779936,0.0009922618],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9220904,0.008455834,0.004871749,0.01822999,0.003919341,0.03051711,0.009224582,0.001001713,0.001689303],"genre_scores_gemma":[0.933443,0.008474044,0.002301242,0.0034078,0.01494742,0.01882322,0.002343656,0.0005797513,0.01567994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01577831,"threshold_uncertainty_score":0.9998657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04154028441403743,"score_gpt":0.3431262730643566,"score_spread":0.3015859886503192,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}